A Low-carbohydrate Diet May Prevent End-stage Renal Failure in Type 2 Diabetes. A Case Report

Overview

Journal Nutr Metab (Lond)

Publisher Biomed Central

Date 2006 Jun 16

PMID 16774676

Citations 4

Authors

Jorgen Vesti Nielsen

Per Westerlund

Per Bygren

Affiliations

Soon will be listed here.

Abstract

An obese patient with type 2 diabetes whose diet was changed from the recommended high-carbohydrate, low-fat type to a low-carbohydrate diet showed a significant reduction in bodyweight, improved glycemic control and a reversal of a six year long decline of renal function. The reversal of the renal function was likely caused by both improved glycemic control and elimination of the patient's obesity. Insulin treatment in type 2 diabetes patients usually leads to weight increase which may cause further injury to the kidney. Although other unknown metabolic mechanisms cannot be excluded, it is likely that the obesity caused by the combination of high-carbohydrate diet and insulin in this case contributed to the patient's deteriorating kidney function. In such patients, where control of bodyweight and hyperglycemia is vital, a trial with a low-carbohydrate diet may be appropriate to avoid the risk of adding obesity-associated renal failure to already failing kidneys.

Citing Articles

Comparative Efficacy of Low-Carbohydrate and Ketogenic Diets on Diabetic Retinopathy and Oxidative Stress in High-Fat Diet-Induced Diabetic Rats.

Jawharji M, Alshammari G, Binobead M, Albanyan N, Al-Harbi L, Yahya M Nutrients. 2024; 16(18).

PMID: 39339674 PMC: 11435414. DOI: 10.3390/nu16183074.

The impact of ketogenic diet on some metabolic and non-metabolic diseases: Evidence from human and animal model experiments.

Galali Y, Zebari S, Aj Jabbar A, Balaky H, Sadee B, Hassanzadeh H Food Sci Nutr. 2024; 12(3):1444-1464.

PMID: 38455178 PMC: 10916642. DOI: 10.1002/fsn3.3873.

Chronic Kidney Disease Interplay with Comorbidities and Carbohydrate Metabolism: A Review.

Kushwaha R, Vardhan P, Kushwaha P Life (Basel). 2024; 14(1).

PMID: 38276262 PMC: 10817500. DOI: 10.3390/life14010013.

Low-Carbohydrate and Very-Low-Carbohydrate Diets in Patients With Diabetes.

Merrill J, Soliman D, Kumar N, Lim S, Shariff A, Yancy Jr W Diabetes Spectr. 2020; 33(2):133-142.

PMID: 32425450 PMC: 7228825. DOI: 10.2337/ds19-0070.

References

Wisse B . The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol. 2004; 15(11):2792-800. DOI: 10.1097/01.ASN.0000141966.69934.21. View

Meloni C, Morosetti M, Suraci C, Pennafina M, Tozzo C, Taccone-Gallucci M . Severe dietary protein restriction in overt diabetic nephropathy: benefits or risks?. J Ren Nutr. 2002; 12(2):96-101. DOI: 10.1053/jren.2002.31762. View

KLAHR S, Levey A, Beck G, Caggiula A, Hunsicker L, Kusek J . The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N Engl J Med. 1994; 330(13):877-84. DOI: 10.1056/NEJM199403313301301. View

Greenwood C, Kaplan R, Hebblethwaite S, Jenkins D . Carbohydrate-induced memory impairment in adults with type 2 diabetes. Diabetes Care. 2003; 26(7):1961-6. DOI: 10.2337/diacare.26.7.1961. View

Gross M, Amann K . Progression of renal disease: new insights into risk factors and pathomechanisms. Curr Opin Nephrol Hypertens. 2004; 13(3):307-12. DOI: 10.1097/00041552-200405000-00007. View

Brehm B, Seeley R, Daniels S, DAlessio D . A randomized trial comparing a very low carbohydrate diet and a calorie-restricted low fat diet on body weight and cardiovascular risk factors in healthy women. J Clin Endocrinol Metab. 2003; 88(4):1617-23. DOI: 10.1210/jc.2002-021480. View

Henry R, Gumbiner B, Ditzler T, Wallace P, Lyon R, Glauber H . Intensive conventional insulin therapy for type II diabetes. Metabolic effects during a 6-mo outpatient trial. Diabetes Care. 1993; 16(1):21-31. DOI: 10.2337/diacare.16.1.21. View

Foster G, Wyatt H, Hill J, McGuckin B, Brill C, Mohammed B . A randomized trial of a low-carbohydrate diet for obesity. N Engl J Med. 2003; 348(21):2082-90. DOI: 10.1056/NEJMoa022207. View

Gannon M, Nuttall F . Effect of a high-protein, low-carbohydrate diet on blood glucose control in people with type 2 diabetes. Diabetes. 2004; 53(9):2375-82. DOI: 10.2337/diabetes.53.9.2375. View

10.

Nielsen J, Jonsson E, Nilsson A . Lasting improvement of hyperglycaemia and bodyweight: low-carbohydrate diet in type 2 diabetes--a brief report. Ups J Med Sci. 2005; 110(1):69-73. DOI: 10.3109/2000-1967-182. View

11.

Soto F, Higa-Sansone G, Copley J, Berho M, Kennedy C, LoMenzo E . Renal failure, glomerulonephritis and morbid obesity: improvement after rapid weight loss following laparoscopic gastric bypass. Obes Surg. 2005; 15(1):137-40. DOI: 10.1381/0960892052993413. View

12.

Nathan D, Genuth S, Lachin J, Cleary P, Crofford O, Davis M . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; 329(14):977-86. DOI: 10.1056/NEJM199309303291401. View

13.

Yancy Jr W, Olsen M, Guyton J, Bakst R, Westman E . A low-carbohydrate, ketogenic diet versus a low-fat diet to treat obesity and hyperlipidemia: a randomized, controlled trial. Ann Intern Med. 2004; 140(10):769-77. DOI: 10.7326/0003-4819-140-10-200405180-00006. View

14.

Morales E, Valero M, Leon M, Hernandez E, Praga M . Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies. Am J Kidney Dis. 2003; 41(2):319-27. DOI: 10.1053/ajkd.2003.50039. View

15.

Sondike S, Copperman N, Jacobson M . Effects of a low-carbohydrate diet on weight loss and cardiovascular risk factor in overweight adolescents. J Pediatr. 2003; 142(3):253-8. DOI: 10.1067/mpd.2003.4. View

16.

Boden G, Sargrad K, Homko C, Mozzoli M, Stein T . Effect of a low-carbohydrate diet on appetite, blood glucose levels, and insulin resistance in obese patients with type 2 diabetes. Ann Intern Med. 2005; 142(6):403-11. DOI: 10.7326/0003-4819-142-6-200503150-00006. View

17.

Hsu C, McCulloch C, Iribarren C, Darbinian J, Go A . Body mass index and risk for end-stage renal disease. Ann Intern Med. 2006; 144(1):21-8. DOI: 10.7326/0003-4819-144-1-200601030-00006. View

18.

Pinto-Sietsma S, Navis G, Janssen W, de Zeeuw D, Gans R, de Jong P . A central body fat distribution is related to renal function impairment, even in lean subjects. Am J Kidney Dis. 2003; 41(4):733-41. DOI: 10.1016/s0272-6386(03)00020-9. View

19.

Wolf G . After all those fat years: renal consequences of obesity. Nephrol Dial Transplant. 2003; 18(12):2471-4. DOI: 10.1093/ndt/gfg427. View

20.

Freedland E . Role of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implications for controlling dietary carbohydrates: a review. Nutr Metab (Lond). 2004; 1(1):12. PMC: 535537. DOI: 10.1186/1743-7075-1-12. View